Ignite Creation Date:
2024-05-06 @ 1:26 PM
Last Modification Date:
2024-10-26 @ 1:14 PM
Study NCT ID:
NCT04021368
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-14
First Post:
2019-07-12
Brief Title:
RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome
Sponsor:
Ryvu Therapeutics SA
Organization:
Ryvu Therapeutics SA
Organization Data
Organization:
Ryvu Therapeutics SA
Class:
INDUSTRY
Study ID:
CLI120-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ryvu Therapeutics SA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None